Point Capital, Inc. (32)

Browse by Contract Category

Contracts

Letter of Intent, dated February 12, 2021, by and between the Company and Aikido Pharma, Inc (Filed With SEC on February 16, 2021)
Master License Agreement, dated February 12, 2021, by and between the Company and the University of Maryland, Baltimore (Filed With SEC on February 16, 2021)
Form of Placement Agent Warrant (Filed With SEC on February 12, 2021)
First Amendment to Employment Agreement, dated January 18, 2021, by and between the Company and Eric Weisblum (Filed With SEC on January 28, 2021)
Form of Advisory Agreement, dated as of April 17, 2020 (Filed With SEC on April 22, 2020)
Form of Lock-Up Agreement, dated as of February 9, 2021 (Filed With SEC on February 10, 2021)
Form of Registration Rights Agreement, dated as of February 9, 2021, between Silo Pharma, Inc. and the signatories thereto (Filed With SEC on February 10, 2021)
Form of Warrant (Filed With SEC on February 10, 2021)
Form of Securities Purchase Agreement, dated as of February 9, 2021, between Silo Pharma, Inc. and the signatories thereto (Filed With SEC on February 10, 2021)
Silo Pharma, Inc. 2020 Omnibus Equity Incentive Plan (Filed With SEC on January 28, 2021)
Sponsored Research Agreement by and between the Company and the University of Maryland, Baltimore (Filed With SEC on January 11, 2021)
Patent License Agreement by and among the Company and Silo Pharma, Inc., a Florida corporation and their affiliates and subsidiaries and AIkido Pharma Inc (Filed With SEC on January 11, 2021)
Form of Lock-Up Agreement, dated as of April 28, 2020 (Filed With SEC on April 29, 2020)
Form of Registration Rights Agreement, dated as of April 28, 2020 (Filed With SEC on April 29, 2020)
Form of Securities Purchase Agreement, dated as of April 28, 2020 (Filed With SEC on April 29, 2020)
Form of Employment Agreement, dated as of April 17, 2020 (Filed With SEC on April 22, 2020)
Form of Consulting Agreement, dated as of April 17, 2020 (Filed With SEC on April 22, 2020)
Form of Subscription Agreement, dated as of April 17, 2020 (Filed With SEC on April 22, 2020)
Form of Exchange Agreement for Series B Preferred Stock, dated as of April 15, 2020 (Filed With SEC on April 22, 2020)
Form of Exchange Agreement for Convertible Notes, dated as of April 15, 2020 (Filed With SEC on April 22, 2020)
Form of Employment Agreement, dated as of April 17, 2020 (Filed With SEC on April 21, 2020)
Form of Advisory Agreement, dated as of April 17, 2020 (Filed With SEC on April 21, 2020)
Form of Consulting Agreement, dated as of April 17, 2020 (Filed With SEC on April 21, 2020)
Form of Subscription Agreement, dated as of April 17, 2020 (Filed With SEC on April 21, 2020)
Form of Exchange Agreement for Series B Preferred Stock, dated as of April 15, 2020 (Filed With SEC on April 21, 2020)
Form of Exchange Agreement for Convertible Notes, dated as of April 15, 2020 (Filed With SEC on April 21, 2020)
Form of registration rights agreement related to Series B preferred shares, dated November 2019, between Uppercut Brands, Inc., and Investors (Filed With SEC on March 20, 2020)
Form of Warrant related to Series B preferred shares, dated November 2019, between Uppercut Brands, Inc., and Investors (Filed With SEC on March 20, 2020)
Form of Securities Purchase Agreement for the purchase of Series B preferred shares, dated November 2019, between Uppercut Brands, Inc., and Investors (Filed With SEC on March 20, 2020)
Form of convertible note agreement with Investors (Filed With SEC on November 13, 2019)
Form of Warrant (Filed With SEC on November 13, 2019)
Form of Securities Purchase Agreement, dated October 2019, between Uppercut Brands, Inc., and Investors (Filed With SEC on November 13, 2019)